← Back to Search

Ultrasound for Scoliosis

N/A
Recruiting
Research Sponsored by Children's National Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare ultrasound imaging to x-rays for detecting scoliosis in children. The hope is that ultrasound will be just as effective as x-rays, but without the radiation exposure.

Eligible Conditions
  • Juvenile Scoliosis
  • Idiopathic Scoliosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Imaging

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Device ArmExperimental Treatment1 Intervention
This is a single arm study comparing an ultrasound with the industry standard of x-ray to detect and monitor scoliosis curvature.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound
2013
Completed Phase 1
~4090

Find a Location

Who is running the clinical trial?

Kitware, Inc.UNKNOWN
National Institute for Biomedical Imaging and Bioengineering (NIBIB)NIH
95 Previous Clinical Trials
21,273 Total Patients Enrolled
Children's National Research InstituteLead Sponsor
223 Previous Clinical Trials
258,365 Total Patients Enrolled

Media Library

Device Arm Clinical Trial Eligibility Overview. Trial Name: NCT03222739 — N/A
Juvenile Scoliosis Research Study Groups: Device Arm
Juvenile Scoliosis Clinical Trial 2023: Device Arm Highlights & Side Effects. Trial Name: NCT03222739 — N/A
Device Arm 2023 Treatment Timeline for Medical Study. Trial Name: NCT03222739 — N/A
~4 spots leftby Dec 2025